Benign multicystic peritoneal mesothelioma (BMPM) is a rare peritoneal tumor diagnosed predominantly in pre-menopausal women. Associated risk factors include endometriosis and pelvic inflammatory disease in women, and prior abdominal surgery in both genders. To date, the pathogenesis of this disease remains controversial with possible etiologies, including a neoplastic versus a reactive process. Given the risk factors, some authors believe that this disease is secondary to a reactive process. However, because some studies describe cases where there is no prior surgical history or inflammatory milieu present, and because of this entity’s predilection for recurrence, some authors believe the origin to be neoplastic. Some genetic and familial associations have also been reported. Malignant transformation is extremely rare, with only two cases reported in the literature, despite the recurrence potential. Like the etiology, the name of this entity is also controversial. Some authors prefer the term “peritoneal inclusion cyst (PCM)” instead of “benign cystic mesothelioma” and argue that the term mesothelioma should only be used when there is evidence of atypia. Most cases of BMPM are discovered incidentally. Others reflect sequela of tumor mass effect. It appears intra-operatively as large, multi-focal, cystic lesions in the peritoneal and pelvic cavity. Diagnosis is achieved through surgical sampling with histopathological examination. Immunobiologically, BMPM exhibits multiple small cystic spaces with flattened lining containing calretinin positive cells without atypical features, mitotic figures, or tissue invasion. Treatment includes cytoreductive surgery. Here we present a case of BMPM in a 60-year-old male – a rare disease in an uncommon patient population.
CanuGL, MedasF, ColumbanoG, et al. Benign multicystic peritoneal mesothelioma in a male patient with previous Wilms’ Tumor: a case report and review of the literature.
RapisardaAMC, CianciA, CarusoS, et al. Benign multicystic mesothelioma and peritoneal inclusion cysts: are they the same clinical and histopathological entities? A systematic review to find an evidence-based management.
Almudévar BerceroE, García-Rostán y PérezGM, García BragadoF, JiménezC. Prognostic value of high serum levels of CA-125 in malignant secretory peritoneal mesotheliomas affecting young women. A case report with differential diagnosis and review of the literature.
EryilmazMK, MutluH, TazegulG, et al.Multiple pelvic cysts in a patient with familial Mediterranean fever: benign cystic mesothelioma.
J Cancer Res Ther. 2017;13(6):1047-9. [PMID:29237974]
BernsteinEM, TateA, SilasiDA, RutherfordT. Benign multicystic mesothelioma: a case report of three sisters. 2009;1(2):e46. [https://doi.org/10.4081/rt.2009.e46].
WangT-B, DaiW-G, LiuDW, ShiHP, DongWG. Diagnosis and treatment of benign multicystic peritoneal mesothelioma.
SafioleasMC, ConstantinosK, MichaelS, KonstantinosG, ConstantinosS, AlkiviadisK. Benign multicystic peritoneal mesothelioma: a case report and review of the literature.
ClementPB, YoungRH. Florid cystic endosalpingiosis with tumor-like manifestations: a report of four cases including the first reported cases of transmural endosalpingiosis of the uterus.
SawhRN, MalpicaA, DeaversMT, LiuJ, SilvaEG. Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status.
HusainAN, ColbyT, OrdonezN, et al. Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.
HwangHC, SheffieldBS, RodriguezS, et al. Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens.
TangjitgamolS, ErlichmanJ, NorthrupH, et al. Benign multicystic peritoneal mesothelioma: cases reports in the family with diverticulosis and literature review.
NomaniL, CalhounBC, BiscottiCV, GrobmyerSR, SturgisCD. Endosalpingiosis of axillary lymph nodes: a rare histopathologic pitfall with clinical relevance for breast cancer staging.